Anthrax PA (Intermediate Domain) Blocking Peptide

Anthrax PA (Intermediate Domain) Blocking Peptide

Product No.: A307

[product_table name="All Top" skus="A307"]

- -
- -
Target
Anthrax Protective Antigen
Product Type
Blocking Peptide
Alternate Names
Anthrax Protective Antigen

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Bacteria
Product Concentration
0.2 mg/ml
Amino Acid Location
16 amino acids near the middle of Anthrax protective antigen.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
16 amino acids near the middle of Anthrax protective antigen.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
Anthrax PA peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
Research Area
Category A Pathogens

References & Citations

1. Lockshin RA, Osborne B, and Zakeri Z. Cell death in the third millennium. Cell Death Differ. 2000; 7:2-7. 2. Cory S, Huang DCS, and Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22:8590-607. 3. Heiser D, Labi V, Erlacher M, et al. The Bcl-2 protein family and its role in the development of neoplastic disease. Exp. Geron. 2004; 39:1125-35. 4. Oltvai ZN, Milliman CL, and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-19.
- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.